Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: An international multicenter cohort study

Not Applicable

Active, not recruiting

• Conditions: Neoplasms

• Registration Number: KCT0008256
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-02-01
• Last Update Posted: 4 April 2023

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 290

Inclusion Criteria

1. Patients who underwent surgery between 2001.01.01 and 2019.08.01
2. All patients who underwent surgery for the treatment of invasive intraductal papillary mucinous tumor
3. Patients who have been followed up for more than 12 months after surgery
4. Patients with available imaging, pathological, and surgical data

Exclusion Criteria

Patients with distant metastasis or unresectable invasive intraductal papillary mucinous tumor confirmed during surgery (Palliative surgery)

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
recurrence;Overall survival

Secondary Outcome Measures

Name	Time	Method
Disease free survival